Intrexon hires prominent researcher and wil relocate corporate headquarters
- August 18, 2009
Intrexon Corp. of Blacksburg is relocating its corporate headquarters to the biotech corridor of Maryland, following the hiring of a prominent cancer researcher who lives near there. That doesn’t mean, however, that the company is pulling up its roots in Blacksburg.
Intrexon has hired Ronald B. Herberman as chief medical officer — oncology. A leading tumor immunologist renowned for his work with natural killer cells, Dr. Herberman, 68, will lead Intrexon’s anti-cancer clinical programs and regulatory affairs. He begins his post Sept. 1. Before joining Intrexon, Herberman was a professor of medicine at the University of Pittsburg School of Medicine and the founding director of its Cancer Institute.
Robert Beech, vice president of business development for the privately-held life sciences firm, says Intrexon plans to maintain and expand its presence at the Virginia Tech Corporate Research Center. He characterized Herberman’s hiring and the shifting of the corporate headquarters as another step in the company’s growth. “We fully intend to maintain a significant facility in Blacksburg,” Beech said.
The company plans to make the Maryland location public in a few weeks. It already has an office in San Francisco. Beech would not comment on the number of employees that might stay in Blacksburg. Intrexon’s Chairman and CEO Randal J. Kirk said in a statement that “we are honored that Dr. Herberman chose to join Intrexon at this point in his highly influential career.”